SYNoPSIS D-glutamyl transferase (GMT) activity was measured in 49 patients with proven myocardial infarction. Twenty-three patients had normal GMT activity and 26 had increased GMT activity. Most of the patients with increased GMT had evidence of liver dysfunction and it is suggested that any increases in serum GMT activity following myocardial infarction are a result of secondary liver damage rather than a release of GMT from cardiac tissue.
determine the probable source of increased GMT activity in serum following myocardial infarction.
Materials and Methods
Fifty-three patients (11 females and 42 males) with a provisional diagnosis of myocardial infarction and increased serum aspartate transaminase (AST) (EC 2.6.1.1.) activity were studied at intervals for up to four weeks after hospital admission or until death (11 cases). In all patients at least three specimens were obtained covering a time span of at least 10 days.
Aspartate transaminase and alanine transaminase (ALT) (EC 2.6.1.2.) (Fingerhut, Ferzola, Marsh, and Levine, 1962) and total LD (Varley, 1967) were measured, and LD isoenzymes separated on cellulose acetate membrane (Preston, Batsakis, and Briere, 1965) on fresh specimens or specimens stored at 4 . The LD isoenzyme patterns were assessed qualitatively against a normal serum on each test run.
D-glutamyl transferase activity was measured using a commercial kit2 which employs the method of Szasz (1969) . For quality control purposes aliquots of a deep frozen pool of serum were thawed and assayed with each batch; the mean activity was 121 U 1 (coefficient of variation 5-1 %). In a series of 50 sera, from staff and outpatients in whom neither hepatobiliary nor cardiac disease was suspected (25 males, 25 females) age range 16-71, assayed for GMT, the mean activity was 15 U I (standard deviation 8 U l) for males and 10 'Boehringer Corporation C-system (catalogue no. 15794 TMBG). Of the 49 patients 26 had increased GMT activity on one or more occasion and 22 of these had increased LD5 isoenzyme present in addition to LD1 and LD2 (see table) . In two of the four patients where no increase in LD5 was noted, GMT activity was only slightly increased, 32, 46, and 55 U/I and 32, 34, and 45 U/i; no other evidence of liver dysfunction was noted and ALT was normal. In the third patient markedly increased activity of GMT (162 U/I) was noted seven days after infarction, though originally only a slight increase (36 U/l) was observed; an episode of congestive cardiac failure was recorded on the sixth day after infarction and ALT was higher than AST till the sixteenth day after infarction. The fourth patient had increased GMT (125 U/i) within two days of infarction and GMT was still slightly increased three weeks later; this patient had a history of three previous myocardial infarctions and episodes of left ventricular failure and congestive cardiac failure were recorded on this admission; ALT was increased in the initial period to 90, 108, and 60 RF units/ml when AST was 262, 387, 145 RF units/ml. There were 23 patients with normal GMT activities throughout the period of study. Five of these patients had slight increases in LD5 in addition to LD1 and LD2. In three of the five ALT was always less than 60 RF units/ml; there was no other record of liver dysfunction. In the other two patients, one had ALT continuously rising and greater than AST, and congestive cardiac failure was demonstrated at necropsy; the other also had congestive cardiac failure demonstrated at necropsy and ALT less than 100 RF units/ml.
The table also shows that most of the patients with only LD1 and LD2 increased had normal GMT activities throughout the period of study; the four exceptions (where serum GMT was increased and only LD1 and LD2 present) have been described above. The table also shows that while most of the patients with LD5 increased in addition to LD1 and LD2 have increased GMT there are five patients where GMT is normal throughout the period of study. These patients also are described above.
In the patients where serum GMT activity was increased after myocardial infarction no consistent or definite pattern of increase of GMT was observed. In patients with normal GMT, ALT was increased in less than half of the patients and was greater than 100 RF units/ml in only one patient. Where GMT was abnormal, ALT activity was nearly always increased.
Discussion
Increases in serum GMT have been reported in a wide variety of liver disorders (Szczeklik et al, 1961; Jacobs, 1972) . Although increases in GMT following myocardial infarction have been reported (Agostini et al, 1965; Ravens et al, 1969; Szczeklik et al, 1972) , little evidence has been found that increased serum GMT activity is derived from damaged human cardiac tissue. Ravens et al (1969) in work on dogs showed an increase in free and particle-bound GMT following experimentally induced myocardial infarction and suggested that this reflected a 'reactive reparative process taking place in infarcted tissue'. Naftalin et al (1969) suggested that increases in serum GMT activity following myocardial infarction were due to secondary liver damage.
Results in this study show that increased serum GMT activity mainly occurs when there is secondary damage to the liver as shown by increases in LD5. Alanine transaminase is a useful index of liver damage (Goldberg, 1971 ) but as ALT is also found in cardiac tissue (Schmidt and Schmidt, 1967) , though proportionally much less than is AST, it is unwise to use increases in serum ALT activity alone as an index of liver damage following myo-cardial infarction. It has also been shown in this study that ALT, a useful index of liver damage, is more often increased in patients with increased GMT activity and favours the argument that increases in serum GMT activity following myocardial infarction are a result of secondary liver damage. Rosalki,Tarlow, and Rau (1971) suggested that increases in serum GMT activity in patients receiving phenobarbitone and other anticonvulsants should be interpreted with caution as he showed that patients receiving these drugs for several months had increased serum GMT activity. Microsomal induction of liver GMT by these drugs may occur within a few days but cell injury may be necessary before GMT is released. One patient who had increased serum GMT activity and only LD1 and LD2 increased had received a number of drugs, including amylobarbitone and phenobarbitone, which may have induced GMT in liver tissue. However, several patients whose serum GMT activity remained normal throughout the period of study had also received these drugs so it is not possible to attribute increased serum GMT activity solely to drug therapy in these patients. Lactate dehydrogenase is not a microsomal enzyme (Schmidt and Schmidt, 1967; Rosalki, 1971 ) and increases in serum LD activities may be due to a different mechanism from that causing increases in serum GMT activity.
Increases in total serum LD activity in liver diseases are usually less marked than increases in AST and ALT (Wilkinson, 1962) , though it has been reported (Latner and Skillen, 1968 ) that increases in LD5 in serum can be seen in liver disease when total LD activity is normal.
Enzyme induction or the sensitivity of LD5 in detecting liver disease could account for some of the results where GMT or LD5 activity alone is increased.
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The results in this study show that increases in serum GMT activity following myocardial infarction occur in 53 % of patients; it appears that the increase in serum GMT activity is a result of damage to liver tissue rather than to the release of enzyme from infarcted cardiac tissue.
